Oxidative stress has been paid increasing attention to as an important causative factor for diabetic vascular complications. Among possible various sources, accumulating evidence has indicated that NAD(P)H oxidase may be the most important source for reactive oxygen species production in diabetic vascular tissues. The mechanisms underlying activation and up-regulation of NAD(P)H oxidase has been supposed to be mediated by high glucose-induced protein kinase C (PKC) activation. In this review article, activation of local renin-angiotensin II system induced by chymase activation is also shown to amplify such a PKC-dependent activation of NAD(P)H oxidase. Additionally, human evidence showing the beneficial effect of antioxidants on diabetic vascular complications. Bilirubin has been recognized as a strong endogenous antioxidant. Here markedly lower prevalence of vascular complications is shown in diabetic patients with Gilbert syndrome, a congenital hyperbilirubinemia, as well as reduced markers of oxidative stress and inflammation. Lastly, statin, angiotensin II receptor blocker, chymase inhibitor, bilirubin and biliverdin, PKC β isoform inhibitor, and glucagon-like peptide-1 analog, are shown to serve as antioxidants and have some beneficial effect on diabetic vascular complications, via inhibiting PKC-NAD(P)H oxidase activation, supporting the notion that this mechanism may be an effective therapeutic target for preventing diabetic vascular complications.

Citations

Citations to this article as recorded by  

• The effects of whey protein on anthropometric parameters, resting energy expenditure, oxidative stress, and appetite in overweight/obese women with type 2 diabetes mellitus: A randomized placebo controlled clinical trial
  Maryam Nouri, Bahram Pourghassem Gargari, Zahra Ghasempour, Vahideh Sadra, Mohammad Asghari Jafarabadi, Arvin Babaei, Pedram Tajfar, Ali Tarighat-Esfanjani
  International Journal of Diabetes in Developing Countries.2024; 44(1): 155.     CrossRef
• Rhodanine-benzamides as potential hits for α-amylase enzyme inhibitors and radical (DPPH and ABTS) scavengers
  Samuel Attah Egu, Irfan Ali, Khalid Mohammed Khan, Sridevi Chigurupati, Urooj Qureshi, Uzma Salar, Zaheer Ul-Haq, Suliman A. Almahmoud, Shatha Ghazi Felemban, Mohsin Ali, Muhammad Taha
  Molecular Diversity.2024;[Epub]     CrossRef
• Research Progress of FGF-21 and CVAI in Type 2 Diabetic Kidney Disease
  央宗 才巴
  Advances in Clinical Medicine.2023; 13(07): 12056.     CrossRef
• Is Subcutaneous Rifamycin Application Superior to Saline Application in Hip Hemiarthroplasty?
  Malik Çelik, Nezih Ziroğlu, Alkan Bayrak
  Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy.2023; 19(2): 186.     CrossRef
• In pursuit of incorporation of markers of oxidative stress in traditional biochemical panels in clinical Chemistry: A risk assessment step in diagnosis and biotherapy
  John Ibhagbemien Anetor, Chukwuemelie Zedech Uche, Gloria Oiyahumen Anetor
  American Journal of Biopharmacy and Pharmaceutical Sciences.2022; 2: 1.     CrossRef
• Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
  Chan-Young Jung, Tae-Hyun Yoo
  Diabetes & Metabolism Journal.2022; 46(2): 181.     CrossRef
• p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats
  Nuttikarn Nokkaew, Podsawee Mongkolpathumrat, Ruttanapong Junsiri, Supawit Jindaluang, Nichagron Tualamun, Niya Manphatthanakan, Nareumon Saleesee, Marisa Intasang, Jantira Sanit, Punyanuch Adulyaritthikul, Kantapich Kongpol, Sarawut Kumphune, Nitirut Ner
  Indian Journal of Clinical Biochemistry.2021; 36(2): 228.     CrossRef
• Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
  Roberta Giordo, Gheyath K. Nasrallah, Anna Maria Posadino, Francesco Galimi, Giampiero Capobianco, Ali Hussein Eid, Gianfranco Pintus
  Antioxidants.2021; 10(2): 224.     CrossRef
• BIOLOGICAL ACTIVE COMPONENTS OF SILENE TOMENTELLA AND THEIR PHARMACOLOGICAL PROPERTIES
  Ugiloy Yusufovna Yusupova, Nurmurod Sheralievich Ramazonov, Khairulla Mamadievich Bobakulov, Feruza Rustamovna Egamova, Vladimir Nikolaevich Syrov, Durbek Abdikhoshimovich Usmanov
  chemistry of plant raw material.2021; (1): 197.     CrossRef
• Chronically Elevated Exogenous Glucose Elicits Antipodal Effects on the Proteome Signature of Differentiating Human iPSC-Derived Pancreatic Progenitors
  Luiza Ghila, Thomas Aga Legøy, Andreas Frøslev Mathisen, Shadab Abadpour, Joao A. Paulo, Hanne Scholz, Helge Ræder, Simona Chera
  International Journal of Molecular Sciences.2021; 22(7): 3698.     CrossRef
• Effect of Type-2 Diabetes Mellitus in Retinopathy Patients on MDA, SOD Activity and its Correlation with HbA1c
  Yali Hou, Mei Lin, Xuan Qiu, Mingjuan He, Yu Zhang, Feifei Guo
  Brazilian Archives of Biology and Technology.2021;[Epub]     CrossRef
• Ameliorative effects of Hydrolea zeylanica in streptozotocin-induced oxidative stress and metabolic changes in diabetic rats
  Sandeep Kumar Swain, Umesh Chandra Dash, Satish Kanhar, Atish Kumar Sahoo
  Journal of Ethnopharmacology.2020; 247: 112257.     CrossRef
• Imbalance in the antioxidant defence system and pro-genotoxic status induced by high glucose concentrations: In vitro testing in human liver cells
  Mattia Acito, Desirée Bartolini, Maria Rachele Ceccarini, Carla Russo, Samuele Vannini, Luca Dominici, Michela Codini, Milena Villarini, Francesco Galli, Tommaso Beccari, Massimo Moretti
  Toxicology in Vitro.2020; 69: 105001.     CrossRef
• Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies
  Poonam Sharma, Varsha Dayma, Aparna Dwivedi, Prabhat K. Baroliya, I.P. Tripathi, Murugesan Vanangamudi, R.S. Chauhan, A.K. Goswami
  Bioorganic Chemistry.2020; 96: 103642.     CrossRef
• Analysis of long non-coding RNA expression profiles in high-glucose treated vascular endothelial cells
  Erqin Xu, Xiaolei Hu, Xiaoli Li, Guoxi Jin, Langen Zhuang, Qiong Wang, Xiaoyan Pei
  BMC Endocrine Disorders.2020;[Epub]     CrossRef
• Potent α-amylase inhibitors and radical (DPPH and ABTS) scavengers based on benzofuran-2-yl(phenyl)methanone derivatives: Syntheses, in vitro, kinetics, and in silico studies
  Irfan Ali, Rafaila Rafique, Khalid Mohammed Khan, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Ashfaq Ur Rehman, Uzma Salar, Muhammad Shahid Iqbal, Muhammad Taha, Shahnaz Perveen, Basharat Ali
  Bioorganic Chemistry.2020; 104: 104238.     CrossRef
• A review of fibroblast growth factor 21 in diabetic cardiomyopathy
  Xiang Zhang, Luo Yang, Xiongfeng Xu, Fengjuan Tang, Peng Yi, Bo Qiu, Yarong Hao
  Heart Failure Reviews.2019; 24(6): 1005.     CrossRef
• Recent advances in the pathogenesis of microvascular complications in diabetes
  Sungmi Park, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim, In-Kyu Lee
  Archives of Pharmacal Research.2019; 42(3): 252.     CrossRef
• Metabolic syndrome status over 2 years predicts incident chronic kidney disease in mid-life adults: a 10-year prospective cohort study
  So Jin Lee, Hun Ju Lee, Hyun jeong Oh, Taehwa Go, Dae Ryong Kang, Jang Young Kim, Ji Hye Huh
  Scientific Reports.2018;[Epub]     CrossRef
• Role of peroxisome proliferator–activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus
  A Tabassum, T Mahboob
  Human & Experimental Toxicology.2018; 37(11): 1187.     CrossRef
• Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis
  Mattias Carlström, Susanna C Larsson
  Nutrition Reviews.2018; 76(6): 395.     CrossRef
• Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model
  Pin Chen, Xiaozhi Shi, Xiangjin Xu, Yiyang Lin, Zhulin Shao, Rongdan Wu, Lihong Huang
  Diabetes Research and Clinical Practice.2018; 137: 173.     CrossRef
• Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials
  Maria E. Balbi, Fernanda S. Tonin, Antonio M. Mendes, Helena H. Borba, Astrid Wiens, Fernando Fernandez-Llimos, Roberto Pontarolo
  Diabetology & Metabolic Syndrome.2018;[Epub]     CrossRef
• Gilbert syndrome in patients with type 1 diabetes-Prevalence, glycemic control, and microalbuminuria
  Sigal Singer, Nurit Pilpel, Orit Pinhas-Hamiel
  Pediatric Diabetes.2017; 18(8): 803.     CrossRef
• Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus
  Kang Hee Ahn, Sang Soo Kim, Won Jin Kim, Jong Ho Kim, Yun Jeong Nam, Su Bin Park, Yun Kyung Jeon, Bo Hyun Kim, In Joo Kim, Yong Ki Kim
  The Korean Journal of Internal Medicine.2017; 32(5): 875.     CrossRef
• Tiron ameliorates high glucose‐induced cardiac myocyte apoptosis by PKCδ‐dependent inhibition of osteopontin
  Ping Jiang, Deling Zhang, Hong Qiu, Xianqi Yi, Yemin Zhang, Yingkang Cao, Bo Zhao, Zhongyuan Xia, Changhua Wang
  Clinical and Experimental Pharmacology and Physiology.2017; 44(7): 760.     CrossRef
• Protective effects of 6-Gingerol on vascular endothelial cell injury induced by high glucose via activation of PI3K-AKT-eNOS pathway in human umbilical vein endothelial cells
  Dan Liu, Mengqing Wu, Yi Lu, Tao Xian, Yupeng Wang, Bowei Huang, Guohua Zeng, Qiren Huang
  Biomedicine & Pharmacotherapy.2017; 93: 788.     CrossRef
• Adenosine signaling in diabetes mellitus and associated cardiovascular and renal complications
  Maria Peleli, Mattias Carlstrom
  Molecular Aspects of Medicine.2017; 55: 62.     CrossRef
• Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients
  Alliny de Souza Bastos, Dana T. Graves, Ana Paula de Melo Loureiro, Carlos Rossa Júnior, Sâmia Cruz Tfaile Corbi, Fausto Frizzera, Raquel Mantuaneli Scarel-Caminaga, Niels Olsen Câmara, Oelisoa M. Andriankaja, Meire I. Hiyane, Silvana Regina Perez Orrico
  Journal of Diabetes and its Complications.2016; 30(8): 1593.     CrossRef
• Agkistrodon acutus-purified protein C activator protects human umbilical vein endothelial cells against H2O2-induced apoptosis
  Shu Li, Yun Hong, Xin Jin, Xianwei Li, Entao Sun, Genbao Zhang, Linming Lu, Liuwang Nie
  Pharmaceutical Biology.2016; 54(12): 3285.     CrossRef
• The impact of mast cells on cardiovascular diseases
  Eva Kritikou, Johan Kuiper, Petri T. Kovanen, Ilze Bot
  European Journal of Pharmacology.2016; 778: 103.     CrossRef
• Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity
  Weiping Sun, Chunping Zeng, Lizhen Liao, Juan Chen, Ying Wang
  Current Medical Research and Opinion.2016; 32(8): 1389.     CrossRef
• Mechanisms for the cardiovascular effects of glucagon-like peptide-1
  H. Poudyal
  Acta Physiologica.2016; 216(3): 277.     CrossRef
• Integrated scientific data bases review on asulacrine and associated toxicity
  Attia Afzal, Muhammad Sarfraz, Zimei Wu, Guangji Wang, Jianguo Sun
  Critical Reviews in Oncology/Hematology.2016; 104: 78.     CrossRef
• Impact of Diabetes and Defective Thyroid Ontogenesis on Audition
  Luciene da Cruz Fernandes
  Journal of Diabetes, Metabolic Disorders & Control.2016;[Epub]     CrossRef
• Serum Total Bilirubin Levels Provide Additive Risk Information over the Framingham Risk Score for Identifying Asymptomatic Diabetic Patients at Higher Risk for Coronary Artery Stenosis
  Jaechan Leem, Eun Hee Koh, Jung Eun Jang, Chang-Yun Woo, Jin Sun Oh, Min Jung Lee, Joon-Won Kang, Tae-Hwan Lim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park, Ki-Up Lee
  Diabetes & Metabolism Journal.2015; 39(5): 414.     CrossRef
• Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study
  Eun-Gyoung Hong, Jung Hun Ohn, Seong Jin Lee, Hyuk Sang Kwon, Sin Gon Kim, Dong Jun Kim, Dong Sun Kim
  BMC Cardiovascular Disorders.2015;[Epub]     CrossRef
• Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes
  Yong-ho Lee, Ehrin J. Armstrong, Gyuri Kim, Jaewon Oh, Seok-Min Kang, Byung-Wan Lee, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Christos S. Mantzoros, Eun Seok Kang
  American Heart Journal.2015; 170(4): 760.     CrossRef
• Common polymorphisms in antioxidant genes are associated with diabetic nephropathy in Type 2 diabetes patients
  Jasna Klen, Katja Goričar, Andrej Janež, Vita Dolžan
  Personalized Medicine.2015; 12(3): 187.     CrossRef
• Increased endogenous serotonin level in diabetic conditions may lead to cardiac valvulopathy via reactive oxygen species regulation
  Tahir Ali, Hina Waheed, Farhat Shaheen, Madiha Mahmud, Qamar Javed, Iram Murtaza
  Biologia.2015; 70(2): 273.     CrossRef
• Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders
  Soo Lim, Philip Barter
  Journal of Atherosclerosis and Thrombosis.2014; 21(10): 997.     CrossRef
• Evidence-Based Practice Use of Incretin-Based Therapy in the Natural History of Diabetes
  Stanley Schwartz
  Postgraduate Medicine.2014; 126(3): 66.     CrossRef
• Low serum bilirubin concentration is a novel risk factor for the development of albuminuria in patients with type 2 diabetes
  Hiroshi Okada, Michiaki Fukui, Muhei Tanaka, Shinobu Matsumoto, Kanae Kobayashi, Hiroya Iwase, Kiichiro Tomiyasu, Koji Nakano, Goji Hasegawa, Naoto Nakamura
  Metabolism.2014; 63(3): 409.     CrossRef
• Serum total bilirubin levels and prevalence of diabetic retinopathy in a Chinese population (中国人群血清总胆红素水平与糖尿病视网膜病变相关性的研究)
  Syeda Sadia Najam, Jichao Sun, Jie Zhang, Min Xu, Jieli Lu, Kan Sun, Mian Li, Tiange Wang, Yufang Bi, Guang Ning
  Journal of Diabetes.2014; 6(3): 221.     CrossRef
• Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk
  Morihiro Matsuda, Iichiro Shimomura
  Hormone Molecular Biology and Clinical Investigation.2014;[Epub]     CrossRef
• Unilateral injection of Aβ25–35 in the hippocampus reduces the number of dendritic spines in hyperglycemic rats
  Zayda Lazcano, Oscar Solis, María Elena Bringas, Daniel Limón, Alfonso Diaz, Blanca Espinosa, Isabel García‐Peláez, Gonzalo Flores, Jorge Guevara
  Synapse.2014; 68(12): 585.     CrossRef
• Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
  Vaibhav B. Patel, Nirmal Parajuli, Gavin Y. Oudit
  Clinical Science.2014; 126(7): 471.     CrossRef
• Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
  Liang-Jun Yan
  Journal of Diabetes Research.2014; 2014: 1.     CrossRef
• Daily intake of vitamin D‐ or calcium‐vitamin D‐fortified Persian yogurt drink (doogh) attenuates diabetes‐induced oxidative stress: evidence for antioxidative properties of vitamin D
  B. Nikooyeh, T. R. Neyestani, N. Tayebinejad, H. Alavi‐Majd, N. Shariatzadeh, A. Kalayi, M. Zahedirad, S. Heravifard, S. Salekzamani
  Journal of Human Nutrition and Dietetics.2014; 27(s2): 276.     CrossRef
• Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases
  Morihiro Matsuda, Iichiro Shimomura
  Reviews in Endocrine and Metabolic Disorders.2014; 15(1): 1.     CrossRef
• PKCδ-dependent Activation of the Ubiquitin Proteasome System is Responsible for High Glucose-induced Human Breast Cancer MCF-7 Cell Proliferation, Migration and Invasion
  Shan Zhu, Feng Yao, Wen-Huan Li, Jin-Nan Wan, Yi-Min Zhang, Zhao Tang, Shahzad Khan, Chang-Hua Wang, Sheng-Rong Sun
  Asian Pacific Journal of Cancer Prevention.2013; 14(10): 5687.     CrossRef
• Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
  Morihiro Matsuda, Iichiro Shimomura
  Obesity Research & Clinical Practice.2013; 7(5): e330.     CrossRef
• Hydrogen Sulfide Suppresses High Glucose–Induced Expression of Intercellular Adhesion Molecule-1 in Endothelial Cells
  Qingbo Guan, Xiaolei Wang, Ling Gao, Jicui Chen, Yuantao Liu, Chunxiao Yu, Nan Zhang, Xu Zhang, Jiajun Zhao
  Journal of Cardiovascular Pharmacology.2013; 62(3): 278.     CrossRef
• Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus
  Jin Hwa Kim, Hak Yeon Bae, Sang Yong Kim
  Diabetes & Metabolism Journal.2013; 37(6): 423.     CrossRef
• Glucose initially inhibits and later stimulates blood ROS generation
  Thomas Stief
  Journal of Diabetes Mellitus.2013; 03(01): 15.     CrossRef
• Oxidative Stress in Cardiovascular Diseases and Obesity: Role of p66Shc and Protein Kinase C
  Elena De Marchi, Federica Baldassari, Angela Bononi, Mariusz R. Wieckowski, Paolo Pinton
  Oxidative Medicine and Cellular Longevity.2013; 2013: 1.     CrossRef
• Toxicological and pharmacological concerns on oxidative stress and related diseases
  Soodabeh Saeidnia, Mohammad Abdollahi
  Toxicology and Applied Pharmacology.2013; 273(3): 442.     CrossRef
• Comparison of antioxidant, α-glucosidase inhibition and anti-inflammatory activities of the leaf and root extracts ofSmilax chinaL.
  Kyoung Kon Kim, Yun Hwan Kang, Dae Jung Kim, Tae Woo Kim, Myeon Choe
  Journal of Nutrition and Health.2013; 46(4): 315.     CrossRef
• Correlation between blood glucose fluctuations and activation of oxidative stress in type 1 diabetic children during the acute metabolic disturbance period
  Di WU, Chun-xiu GONG, Xi MENG, Qiu-lan YANG
  Chinese Medical Journal.2013; 126(21): 4019.     CrossRef
• Oxidative stress and its complications in human health
  Guniz M. Koksal
  Advances in Bioscience and Biotechnology.2012; 03(08): 1113.     CrossRef

Non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases, is caused by the disruption of hepatic lipid homeostasis. It is associated with insulin resistance as seen in type 2 diabetes mellitus. Glucagon-like peptide-1 (GLP-1) is an incretin that increases insulin sensitivity and aids glucose metabolism. In recent in vivo and in vitro studies, GLP-1 presents a novel therapeutic approach against NAFLD by increasing fatty acid oxidation, decreasing lipogenesis, and improving hepatic glucose metabolism. In this report, we provide an overview of the role and mechanism of GLP-1 in relieving NAFLD.

Citations

Citations to this article as recorded by  

• The intestine as an endocrine organ and the role of gut hormones in metabolic regulation
  Rula Bany Bakar, Frank Reimann, Fiona M. Gribble
  Nature Reviews Gastroenterology & Hepatology.2023; 20(12): 784.     CrossRef
• GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
  Riccardo Nevola, Raffaella Epifani, Simona Imbriani, Giovanni Tortorella, Concetta Aprea, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Ferdinando Carlo Sasso
  International Journal of Molecular Sciences.2023; 24(2): 1703.     CrossRef
• From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
  Avilene Rodríguez-Lara, Ascensión Rueda-Robles, María José Sáez-Lara, Julio Plaza-Diaz, Ana I. Álvarez-Mercado
  Pathogens.2023; 12(7): 940.     CrossRef
• Investigating the Opposing Effect of Two Different Green Tea Supplements on Oxidative Stress, Mitochondrial Function and Cell Viability in HepG2 Cells
  Aparna Shil, Chris Davies, Lata Gautam, Justin Roberts, Havovi Chichger
  Journal of Dietary Supplements.2022; 19(4): 459.     CrossRef
• Antiobesity therapeutics with complementary dual‐agonist activities at glucagon and glucagon‐like peptide 1 receptors
  Bong Gyu Park, Gyeong Min Kim, Hye‐Jin Lee, Jae Ha Ryu, Dong‐Hoon Kim, Jae‐Young Seong, Soojeong Kim, Zee‐Yong Park, Young‐Joon Kim, Jaemin Lee, Jae Il Kim
  Diabetes, Obesity and Metabolism.2022; 24(1): 50.     CrossRef
• The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
  Juan Pang, Jia Nuo Feng, Wenhua Ling, Tianru Jin
  Acta Pharmaceutica Sinica B.2022; 12(11): 4040.     CrossRef
• Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes
  Jinsoo Song, In-Jeoung Baek, Sujeong Park, Jinjoo Oh, Deokha Kim, Kyung Song, Mi Kyung Kim, Hye Won Lee, Byoung Kuk Jang, Eun-Jung Jin
  iScience.2022; 25(10): 105135.     CrossRef
• Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
  Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri
  Biology.2022; 11(11): 1622.     CrossRef
• Efficacy and safety of semaglutide for weight management: evidence from the STEP program
  Anastassia Amaro, Danny Sugimoto, Sean Wharton
  Postgraduate Medicine.2022; 134(sup1): 5.     CrossRef
• Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
  Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański
  Nutrients.2021; 13(2): 351.     CrossRef
• Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis
  Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado
  Biomedicines.2021; 9(2): 145.     CrossRef
• A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases
  Changlu Qi, Ping Wang, Tongze Fu, Minke Lu, Yiting Cai, Xu Chen, Liang Cheng
  Briefings in Functional Genomics.2021; 20(1): 42.     CrossRef
• Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome
  Maka Siamashvili, Stephen N. Davis
  Expert Review of Clinical Pharmacology.2021; 14(9): 1081.     CrossRef
• Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD
  Manisha Gupta, Pawan Krishan, Amarjot Kaur, Sandeep Arora, Nirupma Trehanpati, Thakur Gurjeet Singh, Onkar Bedi
  Inflammation Research.2021; 70(7): 765.     CrossRef
• Retrospective analysis (2009–2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India
  Nithyanantham Kamalraj, Madhanagopal Sathishkumar, Mani Arunvignesh, Viswanathan Baskar, Saravanan Jebarani, Anandakumar Amutha, Mohan Deepa, Coimbatore Subramanyam Shanthi Rani, Sundaramoorthy Chandru, Ranjit Unnikrishnan, Ranjit Mohan Anjana, Mardavada
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(5): 102261.     CrossRef
• Gastrointestinal Hormones in Healthy Adults: Reliability of Repeated Assessments and Interrelations with Eating Habits and Physical Activity
  Silke M. Wortha, Katharina A. Wüsten, Veronica A. Witte, Nicole Bössel, Wolfram Keßler, Antje Vogelgesang, Agnes Flöel
  Nutrients.2021; 13(11): 3809.     CrossRef
• Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes
  Jingya Lyu, Hitomi Imachi, Kensaku Fukunaga, Seisuke Sato, Toshihiro Kobayashi, Tao Dong, Takanobu Saheki, Mari Matsumoto, Hisakazu Iwama, Huanxiang Zhang, Koji Murao
  Molecular Metabolism.2020; 34: 16.     CrossRef
• Effects of synbiotic consumption on lipid profile: a systematic review and meta-analysis of randomized controlled clinical trials
  Amir Hadi, Ehsan Ghaedi, Saman Khalesi, Makan Pourmasoumi, Arman Arab
  European Journal of Nutrition.2020; 59(7): 2857.     CrossRef
• Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review
  Xiaodan Lv, Yongqiang Dong, Lingling Hu, Feiyu Lu, Changyu Zhou, Shaoyou Qin
  Endocrinology, Diabetes & Metabolism.2020;[Epub]     CrossRef
• Genetic engineering of novel super long-acting Exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity
  Jong Youl Lee, Taehoon Park, Eunmi Hong, Reeju Amatya, Kyung-Ah Park, Young-Hoon Park, Kyoung Ah Min, Minki Jin, Sumi Lee, Seungmi Hwang, Gu Seob Roh, Meong Cheol Shin
  Biomaterials.2020; 257: 120250.     CrossRef
• A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?
  Rebecca K. Vincent, David M. Williams, Marc Evans
  Diabetes, Obesity and Metabolism.2020; 22(12): 2227.     CrossRef
• A systematic review and meta-analysis of probiotic consumption and metabolic status of athletes
  Atefeh As’Habi, Maryam Nazari, Hossein Hajianfar, Arman Arab, Zeinab Faghfoori
  International Journal of Food Properties.2020; 23(1): 941.     CrossRef
• The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
  Julio Plaza-Díaz, Patricio Solís-Urra, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Miguel Navarro-Oliveros, Francisco Abadía-Molina, Ana I. Álvarez-Mercado
  International Journal of Molecular Sciences.2020; 21(21): 8351.     CrossRef
• Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
  L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Have a heart: failure to increase GLP-1 caused by heart failure increases the risk of diabetes
  Michael J. Ryan
  Clinical Science.2020; 134(23): 3119.     CrossRef
• Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases
  Maite Martínez-Uña, Yaiza López-Mancheño, Carlos Diéguez, Manuel A. Fernández-Rojo, Marta G. Novelle
  International Journal of Molecular Sciences.2020; 21(24): 9368.     CrossRef
• The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors
  Cindy G. Avalos-de León, Mónica B. Jiménez-Castro, María Eugenia Cornide-Petronio, Araní Casillas-Ramírez, Carmen Peralta
  Cells.2019; 8(12): 1599.     CrossRef
• LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet
  Tao Hao, Hongying Chen, Sisi Wu, Haoming Tian
  Molecular Medicine Reports.2019;[Epub]     CrossRef
• Liraglutide alters hepatic metabolism in high-fat fed obese mice: A bioinformatic prediction and functional analysis
  Isabelle Arruda Barbosa, Eloá Mangabeira Santos, Alanna Fernandes Paraíso, Pablo Vinicyus Ferreira Chagas, Luís Paulo Oliveira, João Marcus Oliveira Andrade, Lucyana Conceição Farias, Bruna Mara Aparecida de Carvalho, Alfredo Maurício Batista de Paula, An
  Meta Gene.2019; 20: 100553.     CrossRef
• Dipeptidyl peptidase‐4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats
  Nagat Younan, Samah Elattar, Mira Farouk, Laila Rashed, Suzanne Estaphan
  Physiological Reports.2019;[Epub]     CrossRef
• Microbial Metabolites Determine Host Health and the Status of Some Diseases
  Panida Sittipo, Jae-won Shim, Yun Lee
  International Journal of Molecular Sciences.2019; 20(21): 5296.     CrossRef
• Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats
  Yoo-Cheol Hwang, Da-Hee Oh, Moon Chan Choi, Sang Yeoul Lee, Kyu-Jeong Ahn, Ho-Yeon Chung, Sung-Jig Lim, Sung Hyun Chung, In-Kyung Jeong
  The Korean Journal of Internal Medicine.2018; 33(2): 347.     CrossRef
• Liraglutide attenuates partial warm ischemia-reperfusion injury in rat livers
  Ahmed A. Abdelsameea, Noha A.T. Abbas, Samar M. Abdel Raouf
  Naunyn-Schmiedeberg's Archives of Pharmacology.2017; 390(3): 311.     CrossRef
• Natural alkaloid bouchardatine ameliorates metabolic disorders in high‐fat diet‐fed mice by stimulating the sirtuin 1/liver kinase B‐1/AMPK axis
  Yong Rao, Hong Yu, Lin Gao, Yu‐Ting Lu, Zhao Xu, Hong Liu, Lian‐Quan Gu, Ji‐Ming Ye, Zhi‐Shu Huang
  British Journal of Pharmacology.2017; 174(15): 2457.     CrossRef
• Non-alcoholic fatty liver disease and dyslipidemia: An update
  Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros
  Metabolism.2016; 65(8): 1109.     CrossRef
• Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
  Mi Hae Seo, Jinmi Lee, Seok-Woo Hong, Eun-Jung Rhee, Se Eun Park, Cheol Young Park, Ki Won Oh, Sung Woo Park, Won-Young Lee, Catherine Mounier
  PLOS ONE.2016; 11(12): e0166913.     CrossRef
• The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter
  Young Eun Chon, Kwang Joon Kim, Kyu Sik Jung, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Jae Bock Chung, Kyeong Hye Park, Ji Cheol Bae, Kwang-Hyub Han
  Yonsei Medical Journal.2016; 57(4): 885.     CrossRef
• The role of the gut microbiota in NAFLD
  Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus
  Nature Reviews Gastroenterology & Hepatology.2016; 13(7): 412.     CrossRef
• Extrapancreatic effects of incretin hormones: evidence for weight‐independent changes in morphological aspects and oxidative status in insulin‐sensitive organs of the obese nondiabetic Zucker rat (ZFR)
  Ides M. Colin, Henri Colin, Ines Dufour, Charles‐Edouard Gielen, Marie‐Christine Many, Jean Saey, Bernard Knoops, Anne‐Catherine Gérard
  Physiological Reports.2016;[Epub]     CrossRef
• A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
  Jonathan Temple, Paul Cordero, Jiawei Li, Vi Nguyen, Jude Oben
  International Journal of Molecular Sciences.2016; 17(6): 947.     CrossRef
• Extrapancreatic Effect of Glucagon like Peptide-1
  In-Kyung Jeong
  The Korean Journal of Medicine.2015; 89(4): 404.     CrossRef
• Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet
  Aline B. Santamarina, Juliana L. Oliveira, Fernanda P. Silva, June Carnier, Laís V. Mennitti, Aline A. Santana, Gabriel H. I. de Souza, Eliane B. Ribeiro, Cláudia M. Oller do Nascimento, Fábio S. Lira, Lila M. Oyama, Patricia Aspichueta
  PLOS ONE.2015; 10(11): e0141227.     CrossRef
• Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1
  Mark F McCarty, James J DiNicolantonio
  Open Heart.2015; 2(1): e000205.     CrossRef
• The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
  Huiting Gao, Zhigang Zeng, Han Zhang, Xiaoli Zhou, Lichang Guan, Weiping Deng, Lishu Xu
  Biological & Pharmaceutical Bulletin.2015; 38(5): 694.     CrossRef
• Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance
  Sri Harsha Tella, Marc S. Rendell
  Therapeutic Advances in Endocrinology and Metabolism.2015; 6(3): 109.     CrossRef
• Gut Microbiota: Association with NAFLD and Metabolic Disturbances
  E. Lau, D. Carvalho, P. Freitas
  BioMed Research International.2015; 2015: 1.     CrossRef
• Nonalcoholic fatty liver disease and bariatric surgery in adolescents
  AiXuan Holterman, Juan Gurria, Smita Tanpure, Nerina DiSomma
  Seminars in Pediatric Surgery.2014; 23(1): 49.     CrossRef
• Pediatric non-alcoholic fatty liver disease: New insights and future directions
  Pierluigi Marzuillo
  World Journal of Hepatology.2014; 6(4): 217.     CrossRef
• 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics
  Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M Trovato
  EPMA Journal.2014;[Epub]     CrossRef
• The Role of Medications for the Management of Patients with NAFLD
  Natalia Mazzella, Laura M. Ricciardi, Arianna Mazzotti, Giulio Marchesini
  Clinics in Liver Disease.2014; 18(1): 73.     CrossRef
• Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis
  A. Alisi, G. Bedogni, G. Baviera, V. Giorgio, E. Porro, C. Paris, P. Giammaria, L. Reali, F. Anania, V. Nobili
  Alimentary Pharmacology & Therapeutics.2014; 39(11): 1276.     CrossRef
• The cardiometabolic benefits of glycine: Is glycine an ‘antidote’ to dietary fructose?
  Mark F McCarty, James J DiNicolantonio
  Open Heart.2014; 1(1): e000103.     CrossRef
• Pediatric non-alcoholic fatty liver disease: an increasing public health issue
  S. Berardis, E. Sokal
  European Journal of Pediatrics.2014; 173(2): 131.     CrossRef
• Glucagon‐like peptide‐1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
  H. Kahal, G. Abouda, A. S. Rigby, A. M. Coady, E. S. Kilpatrick, S. L. Atkin
  Clinical Endocrinology.2014; 81(4): 523.     CrossRef
• Comparative analysis of plasma metabolomics response to metabolic challenge tests in healthy subjects and influence of the FTO obesity risk allele
  Simone Wahl, Susanne Krug, Cornelia Then, Anna Kirchhofer, Gabi Kastenmüller, Tina Brand, Thomas Skurk, Melina Claussnitzer, Cornelia Huth, Margit Heier, Christa Meisinger, Annette Peters, Barbara Thorand, Christian Gieger, Cornelia Prehn, Werner Römisch-
  Metabolomics.2014; 10(3): 386.     CrossRef
• Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease
  Eugene Chang, Cheol‐Young Park, Sung Woo Park
  Journal of Diabetes Investigation.2013; 4(6): 517.     CrossRef
• Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
  Pietro Vajro, Selvaggia Lenta, Claudio Pignata, Mariacarolina Salerno, Roberta D’Aniello, Ida De Micco, Giulia Paolella, Giancarlo Parenti
  Italian Journal of Pediatrics.2012; 38(1): 55.     CrossRef

Obstructive sleep apnea (OSA) is a chronic disorder that is prevalent, especially in subjects with obesity or diabetes. OSA is related to several metabolic abnormalities, including diabetes, insulin resistance, hypertension, and cardiovascular diseases. Although Koreans are less obese than Caucasians, the prevalence of OSA is comparable in both groups. Thus, the impact of OSA on metabolism may be similar. Many epidemiologic and experimental studies have demonstrated that OSA is associated with glucose intolerance and insulin resistance via intermittent hypoxia, sleep fragmentation, and sleep deprivation. The effect of continuous positive airway pressure treatment on glucose metabolism is still controversial. Randomized controlled trials are needed to evaluate the ability of OSA treatment to reduce the risk of diabetes and insulin resistance in subjects without diabetes and to ameliorate glucose control in patients with diabetes.

Citations

Citations to this article as recorded by  

• One-month of a low-energy diet, with no additional effect of high-protein, reduces Obstructive Sleep Apnea severity and improve metabolic parameters in obese males
  Camila Maria de Melo, Marcus Vinicius Lúcio dos Santos Quaresma, Mariana Pantaleão del Re, Sandra Maria Lima Ribeiro, Hanna Karen Moreira Antunes, Sonia M. Togeiro, Sergio Tufik, Marco Túlio de Mello
  Clinical Nutrition ESPEN.2021; 42: 82.     CrossRef
• Noncontact Sleep Monitoring With Infrared Video Data to Estimate Sleep Apnea Severity and Distinguish Between Positional and Nonpositional Sleep Apnea: Model Development and Experimental Validation
  Sina Akbarian, Nasim Montazeri Ghahjaverestan, Azadeh Yadollahi, Babak Taati
  Journal of Medical Internet Research.2021; 23(11): e26524.     CrossRef
• Distinguishing Obstructive Versus Central Apneas in Infrared Video of Sleep Using Deep Learning: Validation Study
  Sina Akbarian, Nasim Montazeri Ghahjaverestan, Azadeh Yadollahi, Babak Taati
  Journal of Medical Internet Research.2020; 22(5): e17252.     CrossRef
• A study of glycemic variability in patients with type 2 diabetes mellitus with obstructive sleep apnea syndrome using a continuous glucose monitoring system
  Suhas S. Khaire, Jugal V. Gada, Ketaki V. Utpat, Nikita Shah, Premlata K. Varthakavi, Nikhil M. Bhagwat
  Clinical Diabetes and Endocrinology.2020;[Epub]     CrossRef
• Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link?
  Alessio Pecori, Fabrizio Buffolo, Jacopo Pieroni, Vittorio Forestiero, Elisa Sconfienza, Franco Veglio, Paolo Mulatero, Silvia Monticone
  Hormone and Metabolic Research.2020; 52(06): 366.     CrossRef
• Automated Non-Contact Detection of Head and Body Positions During Sleep
  Sina Akbarian, Ghazaleh Delfi, Kaiyin Zhu, Azadeh Yadollahi, Babak Taati
  IEEE Access.2019; 7: 72826.     CrossRef
• Habitual late sleep initiation is associated with increased incidence of type 2 diabetes mellitus in Korean adults: the Korean Genome and Epidemiology Study
  Ji A Seo, Da Young Lee, Ji Hee Yu, Hyunjoo Cho, Seung Ku Lee, Sooyeon Suh, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Chol Shin, Nan Hee Kim
  Sleep.2019;[Epub]     CrossRef
• Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression
  Tetiana V Serebrovska, Alla G Portnychenko, Tetiana I Drevytska, Vladimir I Portnichenko, Lei Xi, Egor Egorov, Anna V Gavalko, Svitlana Naskalova, Valentina Chizhova, Valeriy B Shatylo
  Experimental Biology and Medicine.2017; 242(15): 1542.     CrossRef
• Features of continuous glycemic profile and glycemic variability in patients with obstructive sleep apnea syndrome
  Chao-Sheng Peng, Yue-An Cao, Yu-Hong Tian, Wen-Luo Zhang, Jing Xia, Lu Yang
  Diabetes Research and Clinical Practice.2017; 134: 106.     CrossRef
• Acute Hypoxic Test in Patients with Prediabetes
  Valerii B. Shatylo, Tatiana V. Serebrovska, Anna V. Gavalko, Egor Egorov, Oleg V. Korkushko
  High Altitude Medicine & Biology.2016; 17(2): 101.     CrossRef
• Obstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat
  Ji Hee Yu, Jae Hee Ahn, Hye Jin Yoo, Ji A Seo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Chol Shin, Nan Hee Kim
  The Korean Journal of Internal Medicine.2015; 30(6): 846.     CrossRef
• Hormonal status and the orexin system in obese patients with obstructive sleep apnea syndrome
  Natalya Viktorovna Strueva, Galina Afanas'evna Melnichenko, Mikhail Gur'evich Poluektov, Larisa Viktorovna Savel'eva, Gulinara Viktorovna Katsya, Nikolay Petrovich Goncharov
  Obesity and metabolism.2015; 12(2): 24.     CrossRef
• Obstructive sleep apnea, hypertension and cardiovascular diseases
  C Gonzaga, A Bertolami, M Bertolami, C Amodeo, D Calhoun
  Journal of Human Hypertension.2015; 29(12): 705.     CrossRef
• Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure
  Elena Olea, Maria Teresa Agapito, Teresa Gallego-Martin, Asuncion Rocher, Angela Gomez-Niño, Ana Obeso, Constancio Gonzalez, Sara Yubero
  Journal of Applied Physiology.2014; 117(7): 706.     CrossRef
• Effect of Continuous Positive Airway Pressure on Type 2 Diabetes Mellitus and Glucose Metabolism
  Lucy Gallegos, Tejal Dharia, Annette B. Gadegbeku
  Hospital Practice.2014; 42(2): 31.     CrossRef
• Association of Obstructive Sleep Apnea and Glucose Metabolism in Subjects With or Without Obesity
  Nan Hee Kim, Nam H. Cho, Chang-Ho Yun, Seung Ku Lee, Dae Wui Yoon, Hyun Joo Cho, Jae Hee Ahn, Ji A. Seo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Chol Shin
  Diabetes Care.2013; 36(12): 3909.     CrossRef

Citations

Citations to this article as recorded by  

• Psychometric Properties of Turkish Version of Hypoglycemia Attitudes and Behavior Scale
  Bahar İNKAYA, Özlem BULANTEKİN DÜZALAN
  Turkish Journal of Family Medicine and Primary Care.2022; 16(2): 247.     CrossRef
• 1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy
  Min Kyeong Kim, Hye Seung Jung, Soo Heon Kwak, Young Min Cho, Kyong Soo Park, Seong Yeon Kim
  Endocrinology and Metabolism.2016; 31(2): 284.     CrossRef

Citations

Citations to this article as recorded by  

• The herbal extract ALS-L1023 from Melissa officinalis reduces weight gain, elevated glucose levels and β-cell loss in Otsuka Long-Evans Tokushima fatty rats
  Yujin Shin, Dongju Lee, Jiwon Ahn, Mijeong Lee, Soon Shik Shin, Michung Yoon
  Journal of Ethnopharmacology.2021; 264: 113360.     CrossRef
• The Effect of Balsamic Vinegar Dressing on Protein and Carbohydrate Digestibility is Dependent on the Food Matrix
  Eleonora Urbinati, Mattia Di Nunzio, Gianfranco Picone, Elena Chiarello, Alessandra Bordoni, Francesco Capozzi
  Foods.2021; 10(2): 411.     CrossRef
• Safety and side effects of apple vinegar intake and its effect on metabolic parameters and body weight: a systematic review
  Tine Louise Launholt, Christina Blanner Kristiansen, Peter Hjorth
  European Journal of Nutrition.2020; 59(6): 2273.     CrossRef
• Nypa fruticans Wurmb. Vinegar’s Aqueous Extract Stimulates Insulin Secretion and Exerts Hepatoprotective Effect on STZ-Induced Diabetic Rats
  Nor Yusoff, Vuanghao Lim, Bassel Al-Hindi, Khairul Abdul Razak, Tri Widyawati, Dwi Anggraini, Mariam Ahmad, Mohd Asmawi
  Nutrients.2017; 9(9): 925.     CrossRef
• Cholesterol in Pancreatic β-Cell Death and Dysfunction
  Rajib Paul, Amarendranath Choudhury, Sabanum Choudhury, Muhammed K. Mazumder, Anupom Borah
  Pancreas.2016; 45(3): 317.     CrossRef
• Chemical Characteristics and Immuno-Stimulatory Activity of Polysaccharides from Fermented Vinegars Manufactured with Different Raw Materials
  Dong-Su Kim, Byung Serk Hurh, Kwang-Soon Shin
  Journal of the Korean Society of Food Science and Nutrition.2015; 44(2): 191.     CrossRef
• Effect and mechanisms of action of vinegar on glucose metabolism, lipid profile, and body weight
  Eleni I Petsiou, Panayota I Mitrou, Sotirios A Raptis, George D Dimitriadis
  Nutrition Reviews.2014; 72(10): 651.     CrossRef
• Chemical Property and Macrophage Stimulating Activity of Polysaccharides isolated from Brown Rice and Persimmon Vinegars
  Dong-Su Kim, Kwang-Soon Shin
  The Korean Journal of Food And Nutrition.2014; 27(6): 1033.     CrossRef
• Vinegar ingestion at mealtime reduced fasting blood glucose concentrations in healthy adults at risk for type 2 diabetes
  Carol S. Johnston, Samantha Quagliano, Serena White
  Journal of Functional Foods.2013; 5(4): 2007.     CrossRef

Citations

Citations to this article as recorded by  

• The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review
  Samuel J Westall, Ram Prakash Narayanan, Simon Watmough, Greg Irving, Niall Furlong, Sid McNulty, Sumudu Bujawansa, Kevin Hardy
  Clinical Medicine.2022; 22(3): 257.     CrossRef
• Analysis of recurrent hypoglycemic events
  Chenchen Ma, Yongming Qu, Haoda Fu
  Journal of Biopharmaceutical Statistics.2021; 31(1): 5.     CrossRef
• ROLE OF OCTREOTIDE IN MANAGEMENT OF SULPHONYLUREA - INDUCED REFRACTORY HYPOGLYCEMIA : A CASE REPORT
  Akshay Kothari, Kiran Shah
  INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021; : 3.     CrossRef
• Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
  João P. Ferreira, Francisco Araújo, Jorge Dores, Lèlita Santos, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana S. Lages, João Conceição, Pedro A. Laires, João Pelicano-Romano, Sílvia Alão
  Diabetes Therapy.2020; 11(10): 2237.     CrossRef
• The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals
  Xiaomeng Yue, Jiuhong Wu, Zhen Ruan, Michael L. Wolden, Lanting Li, Yong Lin
  Value in Health Regional Issues.2020; 21: 17.     CrossRef
• A closer look at the 2019 Beers criteria
  Rishabh Sharma, Malika Arora, Ravinder Garg, Parveen Bansal
  Drugs & Therapy Perspectives.2020; 36(3): 116.     CrossRef
• Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
  Jee Hee Yoo, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2020; 44(6): 828.     CrossRef
• Comparison of clinical pharmacy specialists and usual care in outpatient management of hyperglycemia in Veterans Affairs medical centers
  Heather L Ourth, Kwan Hur, Anthony P Morreale, Francesca Cunningham, Bharat Thakkar, Sherrie Aspinall
  American Journal of Health-System Pharmacy.2019; 76(1): 26.     CrossRef
• Cost‐effectiveness of the psycho‐educational blended (group and online) intervention HypoAware compared with usual care for people with Type 1 and insulin‐treated Type 2 diabetes with problematic hypoglycaemia: analyses of a cluster‐randomized controlled
  M. de Wit, S. M. P. A. Rondags, M. W. van Tulder, F. J. Snoek, J. E. Bosmans
  Diabetic Medicine.2018; 35(2): 214.     CrossRef
• Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles
  Michael J. Tanner, Jingli Wang, Rong Ying, Tisha B. Suboc, Mobin Malik, Allison Couillard, Amberly Branum, Venkata Puppala, Michael E. Widlansky
  American Journal of Physiology-Heart and Circulatory Physiology.2017; 312(3): H515.     CrossRef
• Hazardous factors besides infection in hypoglycemia
  Yu-Jang Su, Yen-Chun Lai, Chia-Jung Liao
  Biomedical Reports.2017; 6(4): 480.     CrossRef
• Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea
  Gyuri Kim, Yong-ho Lee, Mi Hye Han, Eui-Kyung Lee, Chong Hwa Kim, Hyuk Sang Kwon, In Kyung Jeong, Eun Seok Kang, Dae Jung Kim, Massimo Pietropaolo
  PLOS ONE.2016; 11(3): e0151282.     CrossRef
• Costs associated with emergency care and hospitalization for severe hypoglycemia
  G. Veronese, G. Marchesini, G. Forlani, S. Saragoni, L. Degli Esposti, E. Centis, A. Fabbri
  Nutrition, Metabolism and Cardiovascular Diseases.2016; 26(4): 345.     CrossRef
• Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus
  Hyun Min Kim, Jong-Mi Seong, Jaetaek Kim
  Medicine.2016; 95(42): e5016.     CrossRef
• Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes
  Ja Young Jeon, Se Ran Kim, Hae Jin Kim, Dae Jung Kim, Kwan-Woo Lee, Jung-Dong Lee, Seung Jin Han
  Medicine.2016; 95(47): e5365.     CrossRef
• Effectiveness of HypoAware, a Brief Partly Web-Based Psychoeducational Intervention for Adults With Type 1 and Insulin-Treated Type 2 Diabetes and Problematic Hypoglycemia: A Cluster Randomized Controlled Trial
  Stefanie M.P.A. Rondags, Maartje de Wit, Jos W. Twisk, Frank J. Snoek
  Diabetes Care.2016; 39(12): 2190.     CrossRef
• The cost of managing severe hypoglycemic episodes in Type 2 diabetic patients
  Pedro Almeida Laires, João Conceição, Francisco Araújo, Jorge Dores, Catarina Silva, Larry Radican, Ana Nogueira
  Expert Review of Pharmacoeconomics & Outcomes Research.2016; 16(2): 315.     CrossRef
• HypoAware: development and pilot study of a brief and partly web‐based psychoeducational group intervention for adults with Type 1 and insulin‐treated Type 2 diabetes and problematic hypoglycaemia
  S. M. P. A. Rondags, M. de Wit, F. J. Snoek
  Diabetic Medicine.2016; 33(2): 184.     CrossRef
• Hypoglycemia and Health Costs
  Yong-ho Lee, Gyuri Kim, Eun Seok Kang
  The Journal of Korean Diabetes.2016; 17(1): 11.     CrossRef
• Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
  Jae-Seung Yun, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2015; 30(1): 6.     CrossRef
• 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
  Hannah Seok, Ji Hye Huh, Hyun Min Kim, Byung-Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong Soo Cha
  Diabetes & Metabolism Journal.2015; 39(2): 164.     CrossRef
• Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes
  Yun-Mi Yong, Kyung-Mi Shin, Kang-Min Lee, Jae-Young Cho, Sun-Hye Ko, Min-Hyang Yoon, Tae-Won Kim, Jong-Hyun Jeong, Yong-Moon Park, Seung-Hyun Ko, Yu-Bae Ahn
  Diabetes & Metabolism Journal.2015; 39(2): 154.     CrossRef
• Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention
  Badieh Jafari, Mary E. Britton
  Journal of Pharmacy Practice and Research.2015; 45(4): 459.     CrossRef
• HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial
  Stefanie MPA Rondags, Maartje de Wit, Maurits W van Tulder, Michaela Diamant, Frank J. Snoek
  BMC Endocrine Disorders.2015;[Epub]     CrossRef
• Hypoglycemia in Emergency Department
  Yu-Jang Su, Chia-Jung Liao
  Journal of Acute Disease.2015; 4(1): 59.     CrossRef
• Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? Yes, They Continue to Serve Us Well!
  Martin J. Abrahamson
  Diabetes Care.2015; 38(1): 166.     CrossRef
• Association Between Hypoglycemia and Fall-Related Events in Type 2 Diabetes Mellitus: Analysis of a U.S. Commercial Database
  Sumesh Kachroo, Hugh Kawabata, Susan Colilla, Lizheng Shi, Yingnan Zhao, Jayanti Mukherjee, Uchenna Iloeje, Vivian Fonseca
  Journal of Managed Care & Specialty Pharmacy.2015; 21(3): 243.     CrossRef
• Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
  Robert R. Henry, Julio Rosenstock, Douglas Logan, Thomas Alessi, Kenneth Luskey, Michelle A. Baron
  Journal of Diabetes and its Complications.2014; 28(3): 393.     CrossRef
• Management of Diabetes Medications for Patients Undergoing Ambulatory Surgery
  Mary Ann Vann
  Anesthesiology Clinics.2014; 32(2): 329.     CrossRef
• Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura
  Silvia Paz, Diego González Segura, Anna Raya Torres, Luis Lizan
  Avances en Diabetología.2014; 30(2): 34.     CrossRef
• Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study
  A. Lagi, S. Cencetti, F. Lagi
  International Journal of Clinical Practice.2014; 68(8): 1029.     CrossRef
• Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
  Omodele Awoniyi, Rabia Rehman, Samuel Dagogo-Jack
  Current Diabetes Reports.2013; 13(5): 669.     CrossRef
• Diabetes: support for those at risk of malnutrition in the community
  Siobhan Hughes
  British Journal of Community Nursing.2012; 17(11): 529.     CrossRef
• Diabetes patients at risk of malnutrition
  Siobhan Hughes
  Independent Nurse.2012;[Epub]     CrossRef
• Type 2 diabetes: the evolution of a disease
  Harold E Lebovitz
  The British Journal of Diabetes & Vascular Disease.2012; 12(6): 290.     CrossRef
• Severe Hypoglycemia in Patients with Diabetes
  Jae Seung Yun, Seung-Hyun Ko
  Diabetes & Metabolism Journal.2012; 36(4): 273.     CrossRef

Citations

Citations to this article as recorded by  

• Excessive generalized and visceral adiposity is associated with a higher prevalence of diabetic retinopathy in Caucasian patients with type 2 diabetes
  Andrea Tumminia, Agostino Milluzzo, Nunzia Carrubba, Federica Vinciguerra, Roberto Baratta, Lucia Frittitta
  Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 763.     CrossRef
• Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
  Niki Katsiki, Panagiotis Anagnostis, Kalliopi Kotsa, Dimitrios G. Goulis, Dimitri P. Mikhailidis
  Current Pharmaceutical Design.2019; 25(18): 2051.     CrossRef
• Morphologic Comparison of Peripheral Nerves in Adipocyte Tissue from db/db Diabetic versus Normal Mice
  Kyung Ae Lee, Na Young Lee, Tae Sun Park, Heung Yong Jin
  Diabetes & Metabolism Journal.2018; 42(2): 169.     CrossRef
• Gender differences in the perception of difficulty of self-management in patients with diabetes mellitus: a mixed-methods approach
  Hideyo Tsutsui, Kyoko Nomura, Masataka Kusunoki, Tetsuya Ishiguro, Takayoshi Ohkubo, Yoshiharu Oshida
  Diabetology International.2016; 7(3): 289.     CrossRef
• Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus
  Chan-Hee Jung, Bo-Yeon Kim, Kyu-Jin Kim, Sang-Hee Jung, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok
  Cardiovascular Diabetology.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation
  Andrew C. Elton, Vannesa Cedarstrom, Arman Quraishi, Beverly Wuertz, Kevin Murray, Todd W. Markowski, Donna Seabloom, Frank G. Ondrey
  Nutrition and Cancer.2023; 75(3): 1014.     CrossRef
• Steroidogenic Effect of Luteinizing Hormone Receptor Agonists and Metformin in Male Rats with Androgenic Deficiency Caused by Diet-Induced Obesity
  A. A. Bakhtyukov, K. V. Derkach, I. A. Lebedev, V. N. Sorokoumov, A. O. Shpakov
  Journal of Evolutionary Biochemistry and Physiology.2023; 59(5): 1810.     CrossRef
• Steroidogenic Effect of Luteinizing Hormone Receptor Agonists and Metformin in Male Rats with Androgenic Deficiency Caused by Diet-Induced Obesity
  A. A. Bakhtyukov, K. V. Derkach, I. A. Lebedev, V. N. Sorokoumov, A. O. Shpakov
  Российский физиологический журнал им  И  М  Сеченова.2023; 109(10): 1414.     CrossRef
• Metformin in nucleus accumbens core reduces cue‐induced cocaine seeking in male and female rats
  Amy Chan, Alexis Willard, Sarah Mulloy, Noor Ibrahim, Allegra Sciaccotta, Mark Schonfeld, Sade M. Spencer
  Addiction Biology.2022;[Epub]     CrossRef
• Knockdown of Endogenous Nucb2/Nesfatin-1 in the PVN Leads to Obese-Like Phenotype and Abolishes the Metformin- and Stress-Induced Thermogenic Response in Rats
  Daniel Stephan, Natalie Taege, Riccardo Dore, Julica Folberth, Olaf Jöhren, Markus Schwaninger, Hendrik Lehnert, Carla Schulz
  Hormone and Metabolic Research.2022; 54(11): 768.     CrossRef
• Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight
  Vitor Ferreira, Cintia Folgueira, Maria Guillén, Pablo Zubiaur, Marcos Navares, Assel Sarsenbayeva, Pilar López-Larrubia, Jan W. Eriksson, Maria J. Pereira, Francisco Abad-Santos, Guadalupe Sabio, Patricia Rada, Ángela M. Valverde
  Metabolism.2022; 137: 155335.     CrossRef
• Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction
  Xiaorong Wang, Huimin Huang, Yiyi Zhu, Shaoli Li, Peifen Zhang, Jiajun Jiang, Caixi Xi, Lingling Wu, Xingle Gao, Yaoyang Fu, Danhua Zhang, Yiqing Chen, Shaohua Hu, Jianbo Lai
  BioScience Trends.2021; 15(5): 321.     CrossRef
• Therapeutic effect of treatment with metformin and/or 4-hydroxychalcone in male Wistar rats with nonalcoholic fatty liver disease
  Selene de Jesús Acosta-Cota, Elsa Maribel Aguilar-Medina, Rosalío Ramos-Payán, José Guadalupe Rendón Maldonado, José Geovanni Romero-Quintana, Julio Montes-Avila, Juan I. Sarmiento-Sánchez, Carolina Gabriela Plazas-Guerrero, Marcela J. Vergara-Jiménez, Ar
  European Journal of Pharmacology.2019; 863: 172699.     CrossRef
• The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect
  Kira Derkach, Irina Zakharova, Inna Zorina, Andrey Bakhtyukov, Irina Romanova, Liubov Bayunova, Alexander Shpakov, Guillermo López Lluch
  PLOS ONE.2019; 14(3): e0213779.     CrossRef
• Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis
  Chao Luo, Xu Wang, Hanxue Huang, Xiaoyuan Mao, Honghao Zhou, Zhaoqian Liu
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• Metformin alters signaling induced crosstalk and homeostasis in the carcinogenesis paradigm “Epistemology of the origin of cancer”
  Björn L.D.M. Brücher, Ijaz S. Jamall, Obul R. Bandapalli
  4open.2019; 2: 12.     CrossRef
• Melatonin potentiates the effects of metformin on glucose metabolism and food intake in high‐fat‐fed rats
  Rosana F. Dantas‐Ferreira, Helene Raingard, Stephanie Dumont, Carole Schuster‐Klein, Beatrice Guardiola‐Lemaitre, Paul Pevet, Etienne Challet
  Endocrinology, Diabetes & Metabolism.2018;[Epub]     CrossRef
• Molecular Mechanisms of the Effects of Metformin on the Functional Activity of Brain Neurons
  A. O. Shpakov, K. V. Derkach
  Neuroscience and Behavioral Physiology.2018; 48(8): 969.     CrossRef
• Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies
  Ali Taghizadehghalehjoughi, Ahmet Hacimuftuoglu, Meltem Cetin, Afife Busra Ugur, Bianca Galateanu, Yaroslav Mezhuev, Ufuk Okkay, Numan Taspinar, Mehmet Taspinar, Abdullah Uyanik, Betul Gundogdu, Maryam Mohammadzadeh, Kemal Alp Nalci, Polychronis Stivaktak
  Nanomedicine.2018; 13(13): 1595.     CrossRef
• Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
  Dongyu Kang, Zhihui Jing, Ranran Li, Gangrui Hei, Tiannan Shao, Li Li, Mengxi Sun, Ye Yang, Ying Wang, Xiaoyi Wang, Yujun Long, Xiansheng Huang, Renrong Wu
  Frontiers in Psychiatry.2018;[Epub]     CrossRef
• Metformin: not only per os
  Lev M. Berstein
  Expert Review of Endocrinology & Metabolism.2018; 13(2): 63.     CrossRef
• МЕТАБОЛИЧЕСКИЕ ПОКАЗАТЕЛИ И ФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ СИГНАЛЬНЫХ СИСТЕМ ГИПОТАЛАМУСА И ВЛИЯНИЕ НА НИХ МЕТФОРМИНА У МЫШЕЙ С МУТАЦИЕЙ AY/A, ГЕНЕТИЧЕСКИ ПРЕДРАСПОЛОЖЕННЫХ К ОЖИРЕНИЮ, "Доклады Академии наук"
  К.В. Деркач, И.О. Захарова, И.В. Романова, И. И. Зорина, А.Л. Михрина, А.О. Шпаков
  Доклады Академии Наук.2017; (4): 488.     CrossRef
• Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats
  Ichiro Tokubuchi, Yuji Tajiri, Shimpei Iwata, Kento Hara, Nobuhiko Wada, Toshihiko Hashinaga, Hitomi Nakayama, Hiroharu Mifune, Kentaro Yamada, M. Faadiel Essop
  PLOS ONE.2017; 12(2): e0171293.     CrossRef
• Metabolic parameters and functional state of hypothalamic signaling systems in AY/a mice with genetic predisposition to obesity and the effect of metformin
  K. V. Derkach, I. O. Zakharova, I. V. Romanova, I. I. Zorina, A. L. Mikhrina, A. O. Shpakov
  Doklady Biochemistry and Biophysics.2017; 477(1): 377.     CrossRef
• Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice
  Joanne S. Allard, Evelyn J. Perez, Koji Fukui, Priscilla Carpenter, Donald K. Ingram, Rafael de Cabo
  Behavioural Brain Research.2016; 301: 1.     CrossRef
• Intracerebroventricular Metformin Decreases Body Weight But Has Pro-oxidant Effects and Decreases Survival
  Luis Valmor Portela, Jussania Gnoatto, Andressa Wigner Brochier, Clarissa Branco Haas, Adriano Martimbianco de Assis, Afonso Kopczynski de Carvalho, Gisele Hansel, Eduardo Rigon Zimmer, Jean Pierre Oses, Alexandre Pastoris Muller
  Neurochemical Research.2015; 40(3): 514.     CrossRef
• Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
  Young Mi Song, Yong-ho Lee, Ji-Won Kim, Dong-Sik Ham, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Autophagy.2015; 11(1): 46.     CrossRef
• Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: Interference of AMPK/PGC-1α pathway
  Ghorbangol Ashabi, Fariba Khodagholi, Leila Khalaj, Mahdi Goudarzvand, Masoumeh Nasiri
  Metabolic Brain Disease.2014; 29(1): 47.     CrossRef
• Acute oral metformin enhances satiation and activates brainstem nesfatinergic neurons
  Thaïs Rouquet, Pierre Clément, Stéphanie Gaigé, Catherine Tardivel, Julien Roux, Michel Dallaporta, Bruno Bariohay, Jean-Denis Troadec, Bruno Lebrun
  Obesity.2014; : n/a.     CrossRef
• Metformin—mode of action and clinical implications for diabetes and cancer
  Ida Pernicova, Márta Korbonits
  Nature Reviews Endocrinology.2014; 10(3): 143.     CrossRef
• Effects of metformin on weight loss
  Steven K. Malin, Sangeeta R. Kashyap
  Current Opinion in Endocrinology, Diabetes & Obesity.2014; 21(5): 323.     CrossRef
• The effect of ghrelin on MK-801 induced memory impairment in rats
  Fatemeh Goshadrou, Mojtaba Kermani, Abdolaziz Ronaghi, Samad Sajjadi
  Peptides.2013; 44: 60.     CrossRef

Citations

Citations to this article as recorded by  

• Association of dietary intake and nutrition knowledge with diabetes self-management behavior among Bangladeshi type 2 diabetes mellitus adults: A multi-center cross-sectional study
  Shakil Ahmed, Md Sajjadul Haque Ripon, Mohammad Farhan Islam, Ahmad Ullah, Safayet Sultan, Mohammad Sajid, Tanjina Rahman
  Endocrine and Metabolic Science.2024; 14: 100156.     CrossRef
• The effect of mindful eating on dietary behaviour and fasting blood glucose in type 2 diabetes mellitus patients
  Rizki Andriani, Aghnia Kamila, Roofi Asma Putri, Arif Fadhillah, Sabrina Helmi, Delia Septiani
  Healthcare in Low-resource Settings.2024;[Epub]     CrossRef
• Prevalence and the association between clinical factors and Diabetes-Related Distress (DRD) with poor glycemic control in patients with type 2 diabetes: A Northern Thai cross-sectional study
  Achiraya Ruangchaisiwawet, Narumit Bankhum, Krittai Tanasombatkul, Phichayut Phinyo, Nalinee Yingchankul, Shairyzah Ahmad Hisham
  PLOS ONE.2023; 18(11): e0294810.     CrossRef
• Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China
  Yu An, Yinhui Li, Nannan Bian, Xiaoyu Ding, Xiaona Chang, Jia Liu, Guang Wang
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• FAKTOR YANG MEMPENGARUHI KADAR GLUKOSA DARAH PENDERITA DIABETES MELITUS TIPE II USIA 46-65 TAHUN DI KABUPATEN WAKATOBI
  Ekasari Ekasari, Devieka Rhama Dhanny
  Journal of Nutrition College.2022; 11(2): 154.     CrossRef
• The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults
  Liyuan Zhou, Mingqun Deng, Xiao Zhai, Ruiqi Yu, Jieying Liu, Miao Yu, Yuxiu Li, Xinhua Xiao
  Diabetes Therapy.2021; 12(4): 1055.     CrossRef
• Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study
  Fuyuko Takahashi, Yoshitaka Hashimoto, Ayumi Kaji, Ryosuke Sakai, Akane Miki, Takuro Okamura, Noriyuki Kitagawa, Hiroshi Okada, Naoko Nakanishi, Saori Majima, Takafumi Senmaru, Emi Ushigome, Masahide Hamaguchi, Mai Asano, Masahiro Yamazaki, Michiaki Fukui
  Nutrients.2021; 13(5): 1488.     CrossRef
• Dietary Macronutrient Intakes and Mortality among Patients with Type 2 Diabetes
  Cheng-Chieh Lin, Chiu-Shong Liu, Chia-Ing Li, Chih-Hsueh Lin, Wen-Yuan Lin, Mu-Cyun Wang, Shing-Yu Yang, Tsai-Chung Li
  Nutrients.2020; 12(6): 1665.     CrossRef
• Impact of ENPP1 K121Q on Change of Insulin Resistance after Web-Based Intervention in Korean Men with Diabetes and Impaired Fasting Glucose
  Ji Yeon Kang, Sook Hee Sung, Yeon Ju Lee, Tae In Choi, Seung Jin Choi
  Journal of Korean Medical Science.2014; 29(10): 1353.     CrossRef

Citations

Citations to this article as recorded by  

• Nanoparticle-antibody conjugate-based immunoassays for detection of CKD-associated biomarkers
  Monika Chhillar, Deepak kukkar, Preeti Kukkar, Ki-Hyun Kim
  TrAC Trends in Analytical Chemistry.2023; 158: 116857.     CrossRef
• Fecal and Urinary Adipokines as Disease Biomarkers
  Hauke C. Tews, Tanja Elger, Thomas Grewal, Simon Weidlich, Francesco Vitali, Christa Buechler
  Biomedicines.2023; 11(4): 1186.     CrossRef
• Application of SERS-based nanobiosensors to metabolite biomarkers of CKD
  Deepak Kukkar, Monika Chhillar, Ki-Hyun Kim
  Biosensors and Bioelectronics.2023; 232: 115311.     CrossRef
• A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy
  Marwa Mohsen, Ahmed A. Elberry, Alaa Mohamed Rabea, Doaa Mahmoud Khalil, Mohamed E.A. Abdelrahim, Raghda R.S. Hussein
  Canadian Journal of Diabetes.2022; 46(2): 134.     CrossRef
• Serum Neutrophil Gelatinase Associated Lipocalin in Patients with Toxic Nephropathies. Prospective Study
  Lyudmila A. Demidchik, Valentina V. Lee, Dmitriy A. Klyuyev, Ryszhan Y. Bakirova, Vilen B. Molotov-Luchanskiy, Yelena V. Pozdnyakova, Irina V. Beinikova, Semyon S. Bobyrev
  Annals of the Russian academy of medical sciences.2021; 76(2): 142.     CrossRef
• Assessment of Renal Function Status in Steady-State Sickle Cell Anaemic Children Using Urine Human Neutrophil Gelatinase-Associated Lipocalin and Albumin:Creatinine Ratio
  Olatubosun Oladipupo Olawale, Abiodun Folasade Adekanmbi, Ayobola Abimbola Sonuga, Oyebola Oluwagbemiga Sonuga, Samuel Olufemi Akodu, Morufat Mojisola Ogundeyi
  Medical Principles and Practice.2021; 30(6): 557.     CrossRef
• Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional study
  Erhan Aslanhan, David Ojalvo, Ekmek Burak Özsenel, Sema Ucak Basat, Fatih Borlu
  Cardiovascular Endocrinology & Metabolism.2019; 8(3): 82.     CrossRef
• MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
  Qinghua Cao, Xin‐Ming Chen, Chunling Huang, Carol A. Pollock
  FASEB BioAdvances.2019; 1(6): 375.     CrossRef
• Potential serum biomarkers for early detection of diabetic nephropathy
  Tarek Kamal Motawi, Nagwa Ibrahim Shehata, Mahmoud Mohamed ElNokeety, Yasmin Farid El-Emady
  Diabetes Research and Clinical Practice.2018; 136: 150.     CrossRef
• Modern methods of diagnosing chronic kidney disease in patients with diabetes mellitus
  Tatiana N. Markova, Viktoriia V. Sadovskaya, Marina Y. Bespyatova
  Diabetes mellitus.2018; 20(6): 454.     CrossRef
• Evaluation value of neutrophil gelatinase‐associated lipocalin for the renal dysfunction of patients with chronic kidney disease: A meta‐analysis
  Lulu Guo, Yaya Zhao, Zhenzhu Yong, Weihong Zhao
  AGING MEDICINE.2018; 1(2): 185.     CrossRef
• Urinary Tubular Injury Biomarkers Are Associated With ESRD and Death in the REGARDS Study
  Ruth F. Dubin, Suzanne Judd, Rebecca Scherzer, Michael Shlipak, David G. Warnock, Mary Cushman, Mark Sarnak, Chirag Parikh, Michael Bennett, Neil Powe, Carmen A. Peralta
  Kidney International Reports.2018; 3(5): 1183.     CrossRef
• Add-on plasmonic patch as a universal fluorescence enhancer
  Jingyi Luan, Jeremiah J. Morrissey, Zheyu Wang, Hamed Gholami Derami, Keng-Ku Liu, Sisi Cao, Qisheng Jiang, Congzhou Wang, Evan D. Kharasch, Rajesh R. Naik, Srikanth Singamaneni
  Light: Science & Applications.2018;[Epub]     CrossRef
• Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
  Marcelo R. Bacci, Ethel Z. Chehter, Ligia A. Azzalis, Beatriz Costa de Aguiar Alves, Fernando L.A. Fonseca
  Kidney International Reports.2017; 2(2): 152.     CrossRef
• Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
  Bancha Satirapoj, Chagriya Kitiyakara, Asada Leelahavanichkul, Yingyos Avihingsanon, Ouppatham Supasyndh
  BMC Nephrology.2017;[Epub]     CrossRef
• Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy
  Mohamed H. Mahfouz, Adel M. Assiri, Mohammed H. Mukhtar
  Biomarker Insights.2016; 11: BMI.S33191.     CrossRef
• Intra-abdominal Hypertension and Postoperative Kidney Dysfunction in Cardiac Surgery Patients
  Michael A. Mazzeffi, Patrick Stafford, Karin Wallace, Wendy Bernstein, Seema Deshpande, Patrick Odonkor, Ashanpreet Grewal, Erik Strauss, Latoya Stubbs, James Gammie, Peter Rock
  Journal of Cardiothoracic and Vascular Anesthesia.2016; 30(6): 1571.     CrossRef
• Effects of Therapy on Urine Neutrophil Gelatinase-Associated Lipocalin in Nondiabetic Glomerular Diseases with Proteinuria
  Amnuay Sirisopha, Somlak Vanavanan, Anchalee Chittamma, Bunyong Phakdeekitcharoen, Ammarin Thakkinstian, Amornpan Lertrit, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara
  International Journal of Nephrology.2016; 2016: 1.     CrossRef
• Novel urinary biomarkers in pre-diabetic nephropathy
  Vikas Garg, Manish Kumar, Himansu Sekhar Mahapatra, Anubhuti Chitkara, Adesh Kumar Gadpayle, Venketansan Sekhar
  Clinical and Experimental Nephrology.2015; 19(5): 895.     CrossRef
• High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats
  Fenghua Liu, Huayu Yang, Haiping Chen, Mi Zhang, Qing Ma
  Advances in Medical Sciences.2015; 60(1): 133.     CrossRef
• Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
  Sawako Kato, Shoichi Maruyama, Hirofumi Makino, Jun Wada, Daisuke Ogawa, Takashi Uzu, Hisazumi Araki, Daisuke Koya, Keizo Kanasaki, Yutaka Oiso, Motomitsu Goto, Akira Nishiyama, Hiroyuki Kobori, Enyu Imai, Masahiko Ando, Seiichi Matsuo
  Clinical and Experimental Nephrology.2015; 19(6): 1098.     CrossRef
• The inflammation–lipocalin 2 axis may contribute to the development of chronic kidney disease
  Atsushi Hashikata, Akiko Yamashita, Shigeki Suzuki, Shintaro Nagayasu, Takanori Shinjo, Ataru Taniguchi, Mitsuo Fukushima, Yoshikatsu Nakai, Kazuko Nin, Naoya Watanabe, Tomoichiro Asano, Yoshimitsu Abiko, Akifumi Kushiyama, Shoichiro Nagasaka, Fusanori Ni
  Nephrology Dialysis Transplantation.2014; 29(3): 611.     CrossRef
• Urinary Neutrophil Gelatinase Associated Lipocalin as a Marker of Tubular Damage in Type 2 Diabetic Patients with and without Albuminuria
  Abeer A. Al-Refai, Safaa I. Tayel, Ahmed Ragheb, Ashraf G. Dala, Ahmed Zahran
  Open Journal of Nephrology.2014; 04(01): 37.     CrossRef
• Importance of Neutrophil Gelatinase-Associated Lipocalin in Differential Diagnosis of Acute and Chronic Renal Failure
  Seda Ozkan, Polat Durukan, Cemil Kavalci, Ali Duman, Mustafa Burak Sayhan, Omer Salt, Afsin Ipekci
  Iranian Red Crescent Medical Journal.2014;[Epub]     CrossRef
• Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia
  Jing Xiao, Jianying Niu, Xianwu Ye, Qianqian Yu, Yong Gu
  Hypertension in Pregnancy.2013; 32(4): 439.     CrossRef